Michael Pacanowski

Dr. Pacanowski is the Director of the Division of Translational and Precision Medicine in FDA’s Office of Clinical Pharmacology. He and his team of translational scientists focus on the use of innovative tools and approaches to support new drug development and therapeutic individualization through regulatory review, policy development, and research. Specifically, the division focuses on the following areas for the Office of Clinical Pharmacology: pharmacogenomics, biomarker qualification, drugs for rare diseases and inborn errors of metabolism, and genetically targeted therapies. 

Dr. Pacanowski received his Pharm.D. from the Philadelphia College of Pharmacy and his M.P.H. from the University of Florida. He completed a residency in clinical pharmacology at Bassett Healthcare in Cooperstown, NY, and a clinical research fellowship in cardiovascular pharmacogenomics at the University of Florida.